BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6201314)

  • 1. Contributions of immunocytochemistry to gynaecological pathology.
    Kurman RJ
    Clin Obstet Gynaecol; 1984 Apr; 11(1):5-23. PubMed ID: 6201314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoperoxidase technique a review of its application to diseases of the female genital tract.
    Crum CP; Fenoglio CM
    Diagn Gynecol Obstet; 1980; 2(2):103-15. PubMed ID: 6160029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
    Kurman RJ; Ganjei P; Nadji M
    Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunocytochemistry in diagnostic histopathology: its contributions and limitations.
    Mukai K; Rosai J
    Basic Appl Histochem; 1981; 25(3):153-8. PubMed ID: 7032497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of immunochemistry to the diagnosis of human neoplasms in routine histologic sections.
    Muus CJ; Azar HA
    Diagn Immunol; 1986; 4(3):125-39. PubMed ID: 3524962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian cancer: markers, hormones receptors, immunological status].
    Martin PM
    Bull Cancer; 1982; 69(3):248-56. PubMed ID: 6181836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected applications of immunoperoxidase techniques in surgical pathology.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1983; 13(3):240-8. PubMed ID: 6307109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to large glycopeptides in sera from patients with ovarian germ cell tumours.
    Kawata M; Higaki K; Sekiya S; Takamizawa H; Muramatsu T; Okumura K
    Clin Exp Immunol; 1983 Feb; 51(2):401-6. PubMed ID: 6301713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural diagnosis in gynaecological pathology.
    Salazar H; Gonzalez-Angulo A
    Clin Obstet Gynaecol; 1984 Apr; 11(1):25-77. PubMed ID: 6370536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A; Kessler AC
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future research in surgical pathology.
    DeLellis RA
    Am J Clin Pathol; 1981 Mar; 75(3 Suppl):476-82. PubMed ID: 7468538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigen retrieval: its significance and drawbacks in immunohistochemistry].
    Ezaki T
    Kaibogaku Zasshi; 1996 Dec; 71(6):615-28. PubMed ID: 9038004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune system in gynecologic malignancies.
    Barber HR; Dorsett B
    Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833
    [No Abstract]   [Full Text] [Related]  

  • 17. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.
    Kurman RJ; Jenson AB; Lancaster WD
    Am J Surg Pathol; 1983 Jan; 7(1):39-52. PubMed ID: 6299124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and cervical carcinogenesis.
    Stanley MA
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):663-76. PubMed ID: 11563866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic responses to human papillomavirus infection.
    Gissmann L
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):625-39. PubMed ID: 8869949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.